urea has been researched along with Hodgkin Disease in 14 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FERNBACH, DJ | 1 |
| DAVIS, P | 1 |
| KRAKOFF, IH | 1 |
| SAVEL, H | 1 |
| MURPHY, ML | 1 |
| Cipriani, D | 1 |
| Strinchini, A | 1 |
| Howard, N | 1 |
| Marsh, JC | 1 |
| DeConti, RC | 1 |
| Hubbard, SP | 1 |
| Casey, TP | 1 |
| Rothbard, S | 1 |
| Watson, RF | 1 |
| Schmidt, HG | 1 |
| Dietzel, F | 1 |
| Schirmer, G | 1 |
| Caha, A | 1 |
| Rödel, K | 1 |
| Ringleb, D | 1 |
| Britton, KE | 1 |
| Brown, NJ | 1 |
| Weinrach, RS | 1 |
| Joshi, VV | 1 |
| Frei, JV | 1 |
| Young, RC | 1 |
| DeVita, VT | 1 |
| Serpick, AA | 1 |
| Canellos, GP | 1 |
1 trial available for urea and Hodgkin Disease
| Article | Year |
|---|---|
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adolescent; Adrenal Gland Neoplasms; Adult; Alkylating Agents; | 1971 |
13 other studies available for urea and Hodgkin Disease
| Article | Year |
|---|---|
PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).
Topics: Adolescent; Antineoplastic Agents; Child; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukemia; Neop | 1964 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukopenia; Lymphoma; Lymphoma, L | 1964 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leu | 1964 |
Treatment of resistant Hodgkin's disease.
Topics: Drug Resistance; Hodgkin Disease; Nitroso Compounds; Nitrosourea Compounds; Urea | 1971 |
B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Nitroso Compounds; Nitrosourea Compounds; Urea | 1972 |
Acute renal failure in leukaemia and malignant lymphoma.
Topics: Acute Kidney Injury; Blood; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Radioisotope Telet | 1966 |
Azathioprine administration to NZB X NZW hybrid mice with lupus nephritis: beneficial effect complicated by development of malignant lymphomas.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azathioprine; Body Weight; Female; Hodgkin Disease; Ki | 1973 |
Demonstration of collagen in human tissues by immunofluorescence.
Topics: Animals; Antigens; Breast; Breast Neoplasms; Collagen; Fluorescent Antibody Technique; Guanidines; H | 1972 |
[Change in the tubular assimilation of Na plus and K plus in the human kidney under local cobalt 60 irridation. An immediate biological reaction with subsequent quick recovery?].
Topics: Cobalt Radioisotopes; Glomerular Filtration Rate; Hodgkin Disease; Humans; Kidney; Kidney Tubules; P | 1974 |
The use of the radioactive renogram in the reticuloses.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Computers; Female; Hodgkin Disease; Humans; Iodine Rad | 1969 |
Therapy of Hodgkin's disease.
Topics: Benzoates; Chlorambucil; Cyclophosphamide; Glucocorticoids; Hodgkin Disease; Humans; Nitrogen Mustar | 1971 |
Effects of dose and schedule of methylnitrosourea on incidence of malignant lymphoma in adult female mice.
Topics: Animals; Carcinogens; Female; Hodgkin Disease; Mice; Nitroso Compounds; Urea | 1970 |
Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
Topics: Alkylating Agents; Antineoplastic Agents; Hodgkin Disease; Humans; Injections, Intravenous; Leukopen | 1971 |